In breast cancer, surgery, radiotherapy and systemic therapies are strong standards. Newer approaches in Japan such as photo-immunotherapy and personalized vaccines are evaluated alongside — not instead of — standard care in suitable cases.
Photo-immunotherapy is a novel approach based on light-activated targeted molecules.
Personalized vaccine (AFTV) may be evaluated as a supportive protocol aiming to reduce recurrence risk.
Immunotherapy options are planned according to molecular subtype.
Subtype (hormone receptor, HER2, triple-negative) determines the treatment map; your file is reviewed with these details.